propranolol
FDA Approved
Description
Propranolol is a non-selective beta-adrenergic receptor blocking agent used for various cardiovascular conditions. It has been used off-label for management of certain congenital cardiac anomalies and structural heart defects. The medication helps control heart rate and reduce cardiac workload in patients with congenital heart malformations.
Indications & Therapeutic Use
hypertension, cardiac arrhythmias, congenital heart defects supportive care
Global Availability (9 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
propranolol
| Generic Name | propranolol |
| Brands | 1 brand available |
| Active Ingredient | propranolol hydrochloride |
| Drug Class | hypertension |
| Manufacturer | Various generic manufacturers |
| Dosage Forms | oral tablet 10mg, 20mg, 40mg, 80mg; oral solution 20mg/5mL, 40mg/5mL |
| Medical Code | C07AA05 |
| Orphan Status | No |
| Cold Chain | Not Required |
| Lead Time | 7 days |
| Reg. Status | FDA Approved |
| Countries | 9 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations10 Validated Nodes